MANCARDI, GIOVANNI LUIGI
MANCARDI, GIOVANNI LUIGI
Mesenchymal stem cells effectively modulate pathogenic immune response in experimental autoimmune encephalomyelitis.
2007 Gerdoni E; Gallo B; Casazza S; Musio S; Bonanni I; Pedemonte E; Mantegazza R; Frassoni F; Mancardi G; Pedotti R; Uccelli A.
Autologous stem cell transplantation for progressive multiple sclerosis: update of the European Group for Blood and Marrow Transplantation autoimmune diseases working party database.
2006 Saccardi, R; Kozak, T; Bocellityndall, C; Fassas, A; Kazis, A; Havrdova, E; Carreras, E; Saiz, A; Löwenberg, B; te Boekhorst PA, ; Gualandio, F; Openshaw, H; Longo, G; Pagliai, F; Massacesi, L; Deconink, E; Ouyang, J; Nagore, Fj; Besalduch, J; Lisukov, Ia; Bonini, A; Merelli, E; Slavino, S; Gratwohl, A; Passweg, J; Tyndall, A; Steck, Aj; Andolina, M; Capobianco, M; Martin, Jl; Lugaresi, A; Meucci, G; Sáez, Ra; Clark, Re; Fernandez, Mn; Fouillard, L; Herstenstein, B; Koza, V; Cocco, E; Baurmann, H; Mancardi, Gl; Autoimmune Diseases Working Party of EBMT,
Axonal damage and demyelination in long-term dorsal root ganglia cultures from a rat model of Charcot-Marie-Tooth type 1A disease
2006 Nobbio, L; Gherardi, G; Vigo, T; Passalacqua, M; Melloni, E; Abbruzzese, M; Mancardi, G; Nave, Ka; Schenone, A
Autologous HSCT for severe progressive multiple sclerosis in a multicenter trial: impact on disease activity and quality of life.
2005 Saccardi R; Mancardi GL; Solari A; Bosi A; Bruzzi P; Di Bartolomeo P; Donelli A; Filippi M; Guerrasio A; Gualandi F; La Nasa G; Murialdo A; Pagliai F; Papineschi F; Scappini B; Marmont AM.
Experimental Charcot-Marie-Tooth type 1A: A cDNA microarrays analysis
2005 Vigo, T; Nobbio, L; Hummelen, Pv; Abbruzzese, M; Mancardi, G; Verpoorten, N; Verhoeven, K; Sereda, Mw; Nave, Ka; Timmerman, V; Schenone, A
Impairment of PMP22 transgenig Schwann cells differentiatic in culture: implications for Charcot-Marie-Tooth type 1A disease
2004 Nobbio l. ; Vigo T. ; Abbruzzese M. ; Levi G. ; Brancolini C. ; Mantero S. ; Grandis M. ; Benedetti L. ; Mancardi G ;.; Schenone A.;
Altered dosage of peripheral myelin in protein 22 (PMP 22) affects myelin periodicity.
2002 Schenone A.; Nobbio L.; Grandis M.; Benedetti L.; Gherardi G.F.; Abbruzzese M.; Mancardi G.L.; Riekel C.
I farmaci immunomodulatori e immunosoppressori
2002 Mancardi G.L.
Phenotypeof PMP22 transgenic schwann cells in culture
2002 Nobbio, L; Vigo, T; Levi, G; Abbruzzese, M; Mandich, P; Mancardi, Gl; Schenone, A
Sensory-motor polyneuropathy in a patient with mitochondrial myopathy.
2002 Benedetti, L; Grandis, M; Bruno, C; Bado, M; Abbruzzese, M; Mancardi, Gl; Schenone, A
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Mesenchymal stem cells effectively modulate pathogenic immune response in experimental autoimmune encephalomyelitis. | 1-gen-2007 | Gerdoni E; Gallo B; Casazza S; Musio S; Bonanni I; Pedemonte E; Mantegazza R; Frassoni F; Mancardi G; Pedotti R; Uccelli A. | |
| Autologous stem cell transplantation for progressive multiple sclerosis: update of the European Group for Blood and Marrow Transplantation autoimmune diseases working party database. | 1-gen-2006 | Saccardi, R; Kozak, T; Bocellityndall, C; Fassas, A; Kazis, A; Havrdova, E; Carreras, E; Saiz, A; Löwenberg, B; te Boekhorst PA, ; Gualandio, F; Openshaw, H; Longo, G; Pagliai, F; Massacesi, L; Deconink, E; Ouyang, J; Nagore, Fj; Besalduch, J; Lisukov, Ia; Bonini, A; Merelli, E; Slavino, S; Gratwohl, A; Passweg, J; Tyndall, A; Steck, Aj; Andolina, M; Capobianco, M; Martin, Jl; Lugaresi, A; Meucci, G; Sáez, Ra; Clark, Re; Fernandez, Mn; Fouillard, L; Herstenstein, B; Koza, V; Cocco, E; Baurmann, H; Mancardi, Gl; Autoimmune Diseases Working Party of EBMT, | |
| Axonal damage and demyelination in long-term dorsal root ganglia cultures from a rat model of Charcot-Marie-Tooth type 1A disease | 1-gen-2006 | Nobbio, L; Gherardi, G; Vigo, T; Passalacqua, M; Melloni, E; Abbruzzese, M; Mancardi, G; Nave, Ka; Schenone, A | |
| Autologous HSCT for severe progressive multiple sclerosis in a multicenter trial: impact on disease activity and quality of life. | 1-gen-2005 | Saccardi R; Mancardi GL; Solari A; Bosi A; Bruzzi P; Di Bartolomeo P; Donelli A; Filippi M; Guerrasio A; Gualandi F; La Nasa G; Murialdo A; Pagliai F; Papineschi F; Scappini B; Marmont AM. | |
| Experimental Charcot-Marie-Tooth type 1A: A cDNA microarrays analysis | 1-gen-2005 | Vigo, T; Nobbio, L; Hummelen, Pv; Abbruzzese, M; Mancardi, G; Verpoorten, N; Verhoeven, K; Sereda, Mw; Nave, Ka; Timmerman, V; Schenone, A | |
| Impairment of PMP22 transgenig Schwann cells differentiatic in culture: implications for Charcot-Marie-Tooth type 1A disease | 1-gen-2004 | Nobbio l. ; Vigo T. ; Abbruzzese M. ; Levi G. ; Brancolini C. ; Mantero S. ; Grandis M. ; Benedetti L. ; Mancardi G ;.; Schenone A.; | |
| Altered dosage of peripheral myelin in protein 22 (PMP 22) affects myelin periodicity. | 1-gen-2002 | Schenone A.; Nobbio L.; Grandis M.; Benedetti L.; Gherardi G.F.; Abbruzzese M.; Mancardi G.L.; Riekel C. | |
| I farmaci immunomodulatori e immunosoppressori | 1-gen-2002 | Mancardi G.L. | |
| Phenotypeof PMP22 transgenic schwann cells in culture | 1-gen-2002 | Nobbio, L; Vigo, T; Levi, G; Abbruzzese, M; Mandich, P; Mancardi, Gl; Schenone, A | |
| Sensory-motor polyneuropathy in a patient with mitochondrial myopathy. | 1-gen-2002 | Benedetti, L; Grandis, M; Bruno, C; Bado, M; Abbruzzese, M; Mancardi, Gl; Schenone, A |